Isabelle Boutron
Dados Biográficos
| ID | 3092983 |
|---|---|
| NOME | Isabelle Boutron |
| PRENOMES | Isabelle |
| SOBRENOME | Boutron |
| ASSINATURA | BOUTRON I |
| AFILIAÇÕES | Inserm |
| ORCID | 0000-0002-5263-6241 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 18 |
| TOTAL DE CITAÇÕES | 7 |
| TOTAL COMO AUTOR | 18 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2008 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2022 |
| ÍNDICE H | 2 |
A declaração PRISMA 2020
A declaração dos Principais Itens para Relatar Revisões Sistemáticas e Meta-análises (PRISMA), publicada em 2009, foi desenvolvida para ajudar revisores sistemáticos a relatar de forma transparente por que a revisão foi feita, os métodos empregados e o que os autores encontraram. Na última década, os avanços na metodologia e terminologia de revisões sistemáticas exigiram a atualização da diretriz. A declaração PRISMA 2020 substitui a declaração d…
Updating guidance for reporting systematic reviews
The PRISMA 2020 statement
The PRISMA 2020 statement
Declaración PRISMA 2020
La declaración PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses), publicada en 2009, se diseñó para ayudar a los autores de revisiones sistemáticas a documentar de manera transparente el porqué de la revisión, qué hicieron los autores y qué encontraron. Durante la última década, ha habido muchos avances en la metodología y terminología de las revisiones sistemáticas, lo que ha requerido una actualización de esta guía. La…
The PRISMA 2020 statement
PRISMA 2020 explanation and elaboration
The PRISMA 2020 statement
The PRISMA 2020 statement
Day-to-day discovery of preprint–publication links
Preprints promote the open and fast communication of non-peer reviewed work. Once a preprint is published in a peer-reviewed venue, the preprint server updates its web page: a prominent hyperlink leading to the newly published work is added. Linking preprints to publications is of utmost importance as it provides readers with the latest version of a now certified work. Yet leading preprint servers fail to identify all existing preprint–publicatio…
The PRISMA 2020 statement
Background: The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement, published in 2009, was designed to help systematic reviewers transparently report why the review was done, what the authors did and what they found. Over the last decade, there have been many advances in systematic review methodology and terminology, which have necessitated an update to the guideline.Objectives: To develop the PRISMA 2020 statem…
RoB 2
Assessment of risk of bias is regarded as an essential component of a systematic review on the effects of an intervention. The most commonly used tool for randomised trials is the Cochrane risk-of-bias tool. We updated the tool to respond to developments in understanding how bias arises in randomised trials, and to address user feedback on and limitations of the original tool.
Front-of-Pack Labeling and the Nutritional Quality of Students’ Food Purchases
Objectives. To assess the effects of the Nutri-Score label (relative to the Reference Intakes label or no label) on the nutritional quality of students’ food purchases. Methods. A 3-arm randomized controlled trial was conducted in France in 2017; 2907 participants were randomized into 1 of the 3 study arms (Nutri-Score, Reference Intakes, no label) and invited to purchase groceries from an experimental Web-based supermarket. The main outcome was …
Robins-I
Non-randomised studies of the effects of interventions are critical to many areas of healthcare evaluation, but their results may be biased. It is therefore important to understand and appraise their strengths and weaknesses. We developed ROBINS-I (“Risk Of Bias In Non-randomised Studies - of Interventions”), a new tool for evaluating risk of bias in estimates of the comparative effectiveness (harm or benefit) of interventions from studies that d…
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions
Better reporting of interventions
Without a complete published description of interventions, clinicians and patients cannot reliably implement interventions that are shown to be useful, and other researchers cannot replicate or build on research findings. The quality of description of interventions in publications, however, is remarkably poor. To improve the completeness of reporting, and ultimately the replicability, of interventions, an international group of experts and stakeh…
Reporting Methodological Items in Randomized Experiments in Political Science
This article discusses the arguments for using the Consolidated Standards of Reporting Trials (CONSORT) procedures in political science field experiments, with the aim of improving the clarity and transparency of research work and reducing the possibility of bias. The article reviews the background to CONSORT, which is increasingly required for carrying out and reporting trials in healthcare and other disciplines. It sets out the main elements of…
Extending the Consort Statement to Randomized Trials of Nonpharmacologic Treatment
Adequate reporting of randomized, controlled trials (RCTs) is necessary to allow accurate critical appraisal of the validity and applicability of the results. The CONSORT (Consolidated Standards of Reporting Trials) Statement, a 22-item checklist and flow diagram, is intended to address this problem by improving the reporting of RCTs. However, some specific issues that apply to trials of nonpharmacologic treatments (for example, surgery, technica…
Reporting Methodological Items in Randomized Experiments in Political Science
This article discusses the arguments for using the Consolidated Standards of Reporting Trials (CONSORT) procedures in political science field experiments, with the aim of improving the clarity and transparency of research work and reducing the possibility of bias. The article reviews the background to CONSORT, which is increasingly required for carrying out and reporting trials in healthcare and other disciplines. It sets out the main elements of…
Front-of-Pack Labeling and the Nutritional Quality of Students’ Food Purchases
Objectives. To assess the effects of the Nutri-Score label (relative to the Reference Intakes label or no label) on the nutritional quality of students’ food purchases. Methods. A 3-arm randomized controlled trial was conducted in France in 2017; 2907 participants were randomized into 1 of the 3 study arms (Nutri-Score, Reference Intakes, no label) and invited to purchase groceries from an experimental Web-based supermarket. The main outcome was …
Extending the Consort Statement to Randomized Trials of Nonpharmacologic Treatment
Adequate reporting of randomized, controlled trials (RCTs) is necessary to allow accurate critical appraisal of the validity and applicability of the results. The CONSORT (Consolidated Standards of Reporting Trials) Statement, a 22-item checklist and flow diagram, is intended to address this problem by improving the reporting of RCTs. However, some specific issues that apply to trials of nonpharmacologic treatments (for example, surgery, technica…
Reporting Methodological Items in Randomized Experiments in Political Science
This article discusses the arguments for using the Consolidated Standards of Reporting Trials (CONSORT) procedures in political science field experiments, with the aim of improving the clarity and transparency of research work and reducing the possibility of bias. The article reviews the background to CONSORT, which is increasingly required for carrying out and reporting trials in healthcare and other disciplines. It sets out the main elements of…
Better reporting of interventions
Without a complete published description of interventions, clinicians and patients cannot reliably implement interventions that are shown to be useful, and other researchers cannot replicate or build on research findings. The quality of description of interventions in publications, however, is remarkably poor. To improve the completeness of reporting, and ultimately the replicability, of interventions, an international group of experts and stakeh…
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions
Robins-I
Non-randomised studies of the effects of interventions are critical to many areas of healthcare evaluation, but their results may be biased. It is therefore important to understand and appraise their strengths and weaknesses. We developed ROBINS-I (“Risk Of Bias In Non-randomised Studies - of Interventions”), a new tool for evaluating risk of bias in estimates of the comparative effectiveness (harm or benefit) of interventions from studies that d…
RoB 2
Assessment of risk of bias is regarded as an essential component of a systematic review on the effects of an intervention. The most commonly used tool for randomised trials is the Cochrane risk-of-bias tool. We updated the tool to respond to developments in understanding how bias arises in randomised trials, and to address user feedback on and limitations of the original tool.
Front-of-Pack Labeling and the Nutritional Quality of Students’ Food Purchases
Objectives. To assess the effects of the Nutri-Score label (relative to the Reference Intakes label or no label) on the nutritional quality of students’ food purchases. Methods. A 3-arm randomized controlled trial was conducted in France in 2017; 2907 participants were randomized into 1 of the 3 study arms (Nutri-Score, Reference Intakes, no label) and invited to purchase groceries from an experimental Web-based supermarket. The main outcome was …
The PRISMA 2020 statement
Background: The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement, published in 2009, was designed to help systematic reviewers transparently report why the review was done, what the authors did and what they found. Over the last decade, there have been many advances in systematic review methodology and terminology, which have necessitated an update to the guideline.Objectives: To develop the PRISMA 2020 statem…
Updating guidance for reporting systematic reviews
The PRISMA 2020 statement
The PRISMA 2020 statement
Declaración PRISMA 2020
La declaración PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses), publicada en 2009, se diseñó para ayudar a los autores de revisiones sistemáticas a documentar de manera transparente el porqué de la revisión, qué hicieron los autores y qué encontraron. Durante la última década, ha habido muchos avances en la metodología y terminología de las revisiones sistemáticas, lo que ha requerido una actualización de esta guía. La…
The PRISMA 2020 statement
PRISMA 2020 explanation and elaboration
The PRISMA 2020 statement
The PRISMA 2020 statement
Day-to-day discovery of preprint–publication links
Preprints promote the open and fast communication of non-peer reviewed work. Once a preprint is published in a peer-reviewed venue, the preprint server updates its web page: a prominent hyperlink leading to the newly published work is added. Linking preprints to publications is of utmost importance as it provides readers with the latest version of a now certified work. Yet leading preprint servers fail to identify all existing preprint–publicatio…
A declaração PRISMA 2020
A declaração dos Principais Itens para Relatar Revisões Sistemáticas e Meta-análises (PRISMA), publicada em 2009, foi desenvolvida para ajudar revisores sistemáticos a relatar de forma transparente por que a revisão foi feita, os métodos empregados e o que os autores encontraram. Na última década, os avanços na metodologia e terminologia de revisões sistemáticas exigiram a atualização da diretriz. A declaração PRISMA 2020 substitui a declaração d…
Medicine (8 obras) · Meta-analysis and systematic reviews (8 obras) · MEDLINE (7 obras) · Psychology (7 obras) · Checklist (6 obras) · Computer Science (6 obras) · Political science (5 obras) · Systematic review (5 obras) · Delphi Technique in Research (4 obras) · Health Systems, Economic Evaluations, Quality of Life (4 obras)